Coley Pharmaceutical Group, Inc. 4
4 · Coley Pharmaceutical Group, Inc. · Filed Aug 17, 2005
Insider Transaction Report
Form 4
Karobath Manfred E
Director
Transactions
- Conversion
Series F Convertible Preferred Stock
2005-08-15−183,756→ 0 totalExercise: $0.25From: 2005-08-15Exp: 2005-08-15→ Common Stock (46,379 underlying) - Conversion
Series E Convertible Preferred Stock
2005-08-15−17,537→ 0 totalExercise: $0.51From: 2005-08-15Exp: 2005-08-15→ Common Stock (8,983 underlying) - Conversion
Common Stock
2005-08-15−65,502→ 135,783 total - Conversion
Common Stock
2005-08-15+46,379→ 135,783 total - Conversion
Series G Convertible Preferred Stock
2005-08-15−300,000→ 0 totalExercise: $0.22From: 2005-08-15Exp: 2005-08-15→ Common Stock (65,502 underlying) - Conversion
Common Stock
2005-08-15+8,983→ 135,783 total
Footnotes (3)
- [F1]The shares of Series E Convertible Preferred Stock converted automatically to Common Stock upon the completion of the Issuer's initial public offering on August 15, 2005.
- [F2]The shares of Series F Convertible Preferred Stock converted automatically to Common Stock upon the completion of the Issuer's initial public offering on August 15, 2005.
- [F3]The shares of Series G Convertible Preferred Stock converted automatically to Common Stock upon the completion of the Issuer's initial public offering on August 15, 2005.